4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-023385
Options or other derivatives
- Chief Executive Officer acquired 7,500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Collard Craig A Chief Executive Officer | 2023-04-03 | Grant or award · Employee Stock Option (Right to Buy) | +3,000,000 | 3,000,000 | D | ||
| Collard Craig A Chief Executive Officer | 2023-04-03 | Grant or award · Restricted Stock Units | +250,000 | 250,000 | D | ||
| Collard Craig A Chief Executive Officer | 2023-04-03 | Grant or award · Employee Performance Stock Option (Right to Buy) | +4,250,000 | 4,250,000 | D | ||
Loading xslF345X04/doc4.xml…